Need to check if today's candle closes with a hammer candleHello traders!
If you "Follow" us, you can always get new information quickly.
Please also click “Boost”.
Have a good day.
-------------------------------------
(BNGO 1M chart)
It is renewing its low point by falling below the HA-Low indicator point of 6.49.
Touching the HA-Low indicator point means that there is a high possibility of forming a low point.
A decline from the HA-Low indicator point is likely to lead to a renewed low, but also a move to form a bottom.
The 1M chart should be interpreted from a long-term perspective, so it is expected to show movement to form a bottom for a long period of time.
(1W chart)
The HA-Low indicator is falling, showing a stepwise decline.
Accordingly, it is time to buy when it rises above 1.37 and shows support.
(1D chart)
When you see the 1M, 1W chart, you can see that it is absolutely not the time to start trading.
Additionally, the 1D chart also shows that this is not the time to start trading.
However, looking at the current candlestick, there is a possibility that the trend will change.
Accordingly, you need to check whether it shows an up and down movement or sideways movement at the current price range.
If it is supported and rises from the HA-Low indicator, it is likely to rise near the HA-High indicator.
Therefore, if there is a swing up or down from the current price position, the HA-Low indicator will be created, and if it is supported by the created HA-Low indicator and rises above 1.08, there is a possibility of a short-term uptrend.
In order to continue the upward trend, it is highly likely that the HA-High indicator and MS-Signal indicator must rise above.
Therefore, the key is whether it can rise above the current HA-High indicator point of 1.75.
However, since the psychological volume profile section is formed around 1.25, we must first check whether it is possible to break above this section.
Have a good time.
thank you
--------------------------------------------------
- The big picture
The full-fledged upward trend is expected to begin when the price rises above 29K.
This is the section expected to be touched in the next bull market, 81K-95K.
#BTCUSD 12M
1st: 44234.54
2nd: 61383.23
3rd: 89126.41
101875.70-106275.10 (when overshooting)
4th: 13401.28
151166.97-157451.83 (when overshooting)
5th: 178910.15
These are points that are likely to encounter resistance in the future.
We need to see if we can break through these points upward.
Since it is thought that a new trend can be created in the overshooting zone, you should check the movement when this zone is touched.
#BTCUSD 1M
If the general upward trend continues until 2025, it is expected to rise to around 57014.33 and then create a pull back pattern.
1st: 43833.05
2nd: 32992.55
-----------------
Bionanogenomics
Bionano in trouble? Bionano
Short Term - We look to Sell at 1.78 (stop at 2.04)
Preferred trade is to sell into rallies. The trend of lower highs is located at 1.85. Our outlook is bearish. We have a 38.2% Fibonacci pullback level of 1.80 from 2.84 to 1.18. Bespoke resistance is located at 1.85.
Our profit targets will be 1.18 and 1.01
Resistance: 1.85 / 2.50 / 3.00
Support: 1.50 / 1.00 / 0.50
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
BNGO Ready to Break? Bionano Genomics - Short Term - We look to Buy a break of 2.52 (stop at 2.25)
A break of yesterdays high would confirm bullish momentum. Posted a Double Bottom formation. The measured move target is 3.36. We look for gains to be extended today.
Our profit targets will be 3.13 and 3.30
Resistance: 2.50 / 3.00 / 4.00
Support: 2.00 / 1.70 / 1.50
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
BNGO Downtrend BreakoutThe Motly Fool just came out with a nice article on this stock
The Motley Fool noted that Bionano Genomics’ non-sequencing-based optical mapping technology known as the Saphyr System was designed to rapidly characterize extremely long strands of genomic DNA. And the company recently acquired leading genomics data analysis software company BioDiscovery. This acquisition could be a “game-changing business development move for the company and its shareholders,” says The Motley Fool report.
It was a perfect time to cause a downtrend breakout and kick off a rally.
It's kind of messed up how publishers can manipulate stocks like this but such is the game.
Save half for a buy in on a dip to test the top of the trendline.
Targets $9 , $12 , ATH+
BNGO ready for a breakout?Bionano Genomics, it is in the field of gene sequencing.
The company`s product, Saphyr, uses optical genome mapping to help detect structural variations in gene sequencing.
Bionano recently acquired BioDiscovery for $100 million, which is a leader in clinical software production.
The acquisition may facilitate adoption of the Saphyr system, in $4 billion market segment.
I see a strong support at this level and an upside, according to BTIG Research of $10 per share.
BNGO - CHART UPDATEBNGO: everything above 4.29 is bullish. GAP fill is still possible. Trading below 5.35 --> focus on gap fill. Trading above 5.60 --> Target 6 USD. 5.50 is our new support & a possible bounce zone. Very hard to give exact price targets in the daily trading of small caps with low volume. Therefore I only give fewer updates for BNGO. Otherwise it could confuse some people;)
BNGO Can we see this run till next earnings report ?The short volume ratio is decreasing which means good news for us. - Fintel
Also looks like it's time for a reversal on the 1HR MACD so we could be in for a breakout with a high upside. All I'm hearing is nothing but good news associated with Bionano Genomics.
However, we cannot fail to ignore the declining revenues every year. Keep an eye on this till the next earnings report.
If the volume increase holds true,
I'll be taking my profit around 15$ which should be a realistic target. If it runs further, 18$-20$ is definitely possible and will have to re-evaluate.
Regardless, for now, we are Bullish!
(Disclaimer)
(This is not financial advice, just my opinion)
NASDAQ:BNGO NASDAQ:BNGO
BNGO bearish?I have the feeling that Bionano Genomics ($BNGO) is not bullish on the daily timeframe. We can see less volume and the MACD is about to cross down.
But everything is possible! A great news ($ARK buying shares) can overturn the current market situation...
What's your opinion on this? Your comments are welcome.
##############
Take into account that fundamentals (news) supplement technical analysis. A trader does not use a crystal ball to predict the future (news and people's reactions). Additionally technical analysis is not an exact science. It involves a degree of subjectivity.
Legal disclaimer: I am not a financial advisor. The advice here given is not a financial advice even though my excitement might make it look like such. This account shouldn't be followed by anyone expecting something from me. You trade at your own risk and nobody can guarantee you results. Even if someone could, I don't.
bionano genomics stock AnalysiBased on Fundamental and Technical Analysis, the idea is to go long.
Bionano's symposium focused on the ability of its Saphyr optical genome mapping (OGM) system to analyze the genomes of people with diseases resulting from so-called genomic repeats, or repetitive sequences that can alter the function of genes.
NASDAQ:BNGO
BIONANO GENOMICS ($BNGO): SOON $10 🚀🚀🚀$BNGO can go ahead and hit $10 real quick.
Your comments are welcome.
##############
Legal disclaimer: I am not a financial advisor. The advice here given is not a financial advice even though my excitement might make it look like such. This account shouldn't be followed by anyone expecting something from me. You trade at your own risk and nobody can guarantee you results. Even if someone could, I don't.
BNGO BioNano Genomics upside potenial, huge volume comingBioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space.
Net Income $-29,820,000.00
Market Cap $69.23 million
Annual Sales $10.13 million
BNGO exceeded EARNINGS ESTIMATES in Q1 and on 7/17/2020 Maxim Group Reiterated the Rating to Buy and a target of $2.00 per share.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.